AB vs BUD: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: AB is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AB and BUD share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AB and BUD exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

AllianceBernstein is a global investment management firm that runs research-intensive active strategies across equities, fixed income, alternatives, and multi-asset portfolios. It serves three client channels: Institutional Services (pensions, endowments, insurers, and central banks), Retail Services (mutual funds and separately managed accounts), and Private Wealth Management for high-net-worth families. Assets under management reached about $905 billion by mid-2026, split fairly evenly across institutional, retail, and private-wealth clients, and the firm earns the bulk of its revenue from asset-based management fees plus performance fees and Bernstein Research services. Equitable Holdings (EQH) is the controlling owner, holding a large majority economic interest through the operating partnership.

Full AB guide

Anheuser-Busch InBev SA/NV is the largest beer company in the world, formed through a series of mega-mergers that combined Anheuser-Busch, InBev, and SABMiller. It is headquartered in Leuven, Belgium, and its US-listed shares trade as an American Depositary Receipt (ADR) under the ticker BUD, so US investors own a receipt representing the underlying foreign shares. Its portfolio spans global brands such as Budweiser, Corona, and Stella Artois, alongside Michelob Ultra and a wide set of local champion brands that lead individual markets across Latin America, Africa, and Asia Pacific.

Full BUD guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AB drivers: Assets under management scale; Distribution-driven income.
• BUD drivers: Premiumization and pricing power; Deleveraging the balance sheet.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: AB's revenue is tightly linked to markets, so a downturn in equities or bonds would shrink the fee base and the distribution alongside it. For BUD, the clearest risk is the debt load itself: while falling, it remains large, and slow deleveraging or higher interest rates would keep pressure on the stock.

Pick AB if you believe its drivers more; BUD if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AB and BUD guides.

AB. AB trades at a modest earnings multiple (roughly 11x trailing) that reflects its status as a mature, market-sensitive asset manager rather than a growth stock. The standout feature is the high distribution yield near 9%, which is a function of the MLP pass-through structure that returns almost all cash to unitholders each quarter. Because the payout floats with adjusted profit, both the yield and the multiple should be read against the risk that markets or flows turn negative.

BUD. Figures are approximate and tied to the asOf date; verify live numbers before acting. For AB InBev, much of the valuation debate centers on the pace of debt reduction rather than on quarterly volume: faster deleveraging is widely seen as the catalyst that could re-rate the shares, while stalled progress or currency headwinds can weigh on them. As an ADR, reported results and any dividend are translated from foreign currencies, so a strong US dollar can dampen returns for US holders independent of how the underlying business performs.

Headline figures (approximate, JULY 2026): AB shows assets under management ~$905B, revenue (ttm, gaap) ~$4.5B, q1 2026 adjusted epu ~$0.83, quarterly distribution ~$0.83/unit; BUD shows business model World's largest brewer; sells beer and Beyond Beer at global scale, with growth driven by premiumization, pricing, and emerging-market volume, recent revenue Q1 2026 revenue of roughly $15.3 billion, up about 12% year over year on price and mix rather than large volume gains, recent earnings Q1 2026 adjusted earnings per share reached a record first-quarter level, up sharply from a year earlier, leverage Net-debt-to-EBITDA around 2.9 times at end of 2025, with a stated goal of moving toward roughly 2.0 times over time.

AB and BUD are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AB and BUD exposure against your real portfolio. It is not an investment adviser.